Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 28, 2004
ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight menD C Chan, G F Watts, P H R Barrett, et al.Human Mutation|July 23, 2003
Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemiaA J Whitfield, A D Marais, K Robertson, et al.Journal of Hypertension|October 11, 2001
Association between the endothelin-1 gene Lys198Asn polymorphism blood pressure and plasma endothelin-1 levels in normal and pre-eclamptic pregnancyA E Barden, C E Herbison, L J Beilin, et al.Journal of Lipid Research|September 19, 1998
Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese menF M Riches, G F Watts, F M van Bockxmeer, et al.Journal of Molecular Evolution|May 5, 2000
Duplication and diversification of the apolipoprotein CI (APOCI) genomic segment in association with retroelementsE M Freitas, S Gaudieri, W J Zhang, et al.Annals of Clinical Biochemistry|February 16, 2008
Familial lipoprotein lipase deficiency caused by known (G188E) and novel (W394X) LPL gene mutationsA J Hooper, G M Crawford, J M Brisbane, et al.DNA Sequence : the Journal of DNA Sequencing and Mapping|October 16, 1999
Sequencing of 42kb of the APO E-C2 gene cluster reveals a new gene: PEREC1E M Freitas, W J Zhang, J P Lalonde, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 12, 2016
Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapyD C Chan, J Pang, P H R Barrett, et al.Diabetologia|March 3, 2007
The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetesM K Bulsara, C D J Holman, F M van Bockxmeer, et al.Stroke|December 1, 2004
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trialP Dusitanond, J W Eikelboom, G J Hankey, et al.Pageof 4